BioSante Pharmaceuticals, Inc. (BPAX)

[MrLingo]

Listen to Live Conference Call on BPAX today!

Its on their site under webcast: http://www.biosantepharma.com/Webcasts.php

Listen to their conference call. It explains the results in detail. It's not that the drug did not work, it worked as they expected by producing an increase in testosterone, increasing testosterone over 50%. The only thing is that the placebo gave similar reactions to testosterone increase, without their testosterone levels show a change.

Why? they believe that the constant daily reminders that the test subjects were subjected to, might have been exciting in itself.

So did the drug work as expected, YES it raised testosterone and increased libido.

Did the placebo produce expected results, YES AND NO. It did not raise the testosterone, but it did increase libido. So it did the job of a placebo to trick you into producing a response.

Here is my belief:

If the drug was approved, it would do what it was designed to do and be successful,

If the placebo worked because of the constant reminders and daily journal and questionnaires, keeping the content fresh in the users mind. This would not be the case with actual users after FDA approval. They will not get daily reminders and asked to write in a journal or answer questions that get them excited.

In their next test of the drug they really need to take the constant reminders (information overload) out of the test and make it a true REAL WORLD test.

This will be the first drug in its category and it is currently the only one at the head of the pack. So if BPAX decides to continue with this product (they should) their current income can more than sustain the costs.

They have products that are FDA approved, this alone should give the stock at least a $1+ share price. They have a cancer drug that is near FDA approval too, the great thing about this drug is that they are not paying for the research, but they stand to benefit if/when it gets approved. No money is out of pocket.

With over a $50+ million market cap, they have money to continue, buy additional products, enhance current products.

This company is a solid $1.50 p/s given all they have going for them.

I know of too many biotech companies with over a $1 p/s price and they only have one drug in the developmental stage with a long shot at getting FDA approved.

What are your thoughts?